OrbiMed’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,923,139
Closed -$31.4M 145
2021
Q4
$31.4M Hold
1,923,139
0.4% 66
2021
Q3
$41.2M Buy
+1,923,139
New +$41.2M 0.45% 62